On the other hand, Handy et al. observed a significant progressive increase in the serum ZFP level in patients with more pronounced liver damage (from control to simple steatosis to NASH, respectively) [13]. The gene discussed is ZKSCAN7; the disease is metabolic dysfunction-associated steatohepatitis.